Scilex Holding Company (NASDAQ:SCLX) has a beta value of 0.94 and has seen 0.72 million shares traded in the recent trading session. The company, currently valued at $88.13M, closed the recent trade at $0.36 per share which meant it gained $0.01 on the day or 4.50% during that session. The SCLX stock price is -538.89% off its 52-week high price of $2.30 and 41.67% above the 52-week low of $0.21.
The consensus among analysts is that Scilex Holding Company (SCLX) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 2 have rated it as a Hold, with 2 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -0.09.
Scilex Holding Company (NASDAQ:SCLX) trade information
Sporting 4.50% in the green today, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the SCLX stock price touched $0.36 or saw a rise of 5.09%. Year-to-date, Scilex Holding Company shares have moved -15.06%, while the 5-day performance has seen it change 24.30%. Over the past 30 days, the shares of Scilex Holding Company (NASDAQ:SCLX) have changed -1.15%.
Scilex Holding Company (SCLX) estimates and forecasts
The company’s shares have lost -67.37% over the past 6 months. Revenue growth from the last financial year stood is estimated to be 21.75%.
2 analysts offering their estimates for the company have set an average revenue estimate of 15.31M for the current quarter. 4 have an estimated revenue figure of 25.88M for the next ending quarter. Year-ago sales stood 13.46M and 10.88M respectively for this quarter and the next, and analysts expect sales will grow by 13.72% for the current quarter and 21.75% for the next.
SCLX Dividends
Scilex Holding Company is expected to release its next earnings report in April this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Scilex Holding Company (NASDAQ:SCLX)’s Major holders
The top two institutional holders are ARMISTICE CAPITAL, LLC with over 11.95 million shares worth more than $23.06 million. As of 2024-06-30, ARMISTICE CAPITAL, LLC held 9.9428% of shares outstanding.
The other major institutional holder is RAFFERTY ASSET MANAGEMENT, LLC, with the holding of over 0.62 million shares as of 2024-06-30. The firm’s total holdings are worth over $1.2 million and represent 0.516% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF and Vanguard Total Stock Market Index Fund. As of Dec 31, 2024, the former fund manager holds about 2.44% shares in the company for having 5.94 shares of worth $2.14 million while later fund manager owns 3.71 shares of worth $1.34 million as of Dec 31, 2024, which makes it owner of about 1.53% of company’s outstanding stock.
